FindTrial
Sign In

Effect of Acupoint injection on preventing nausea and vomiting after Gynecological Laparoscopic surgery

Effect of Acupoint injection on preventing nausea and vomiting after Gynecological Laparoscopic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018486
Enrollment
Unknown
Registered
2018-09-20
Start date
2018-09-20
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting after surgery

Interventions

Blank control group:navoban 5mg intravenous injection and dexamethasone 5mg intravenous infusion
Acupoint injection group:navoban 5mg intravenous injection and dexamethasone 5mg acupoint injection
Saline group:navoban 5mg intravenous injection and saline 1ml acupoint injection
Simple acupoint stimulation group:navoban 5mg intravenous injection and simple acupoint stimulation
Para-acupoint opening group:navoban 5mg intravenous injection and dexamethasone 5mg 2cm injection beside acupoint

Sponsors

Shaanxi Province Tumor Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: A total of 600 female patients undergoing laparoscopic surgery under general anesthesia were enrolled in this study. Aged 18-70 years old; BMI was 18-29.5; ASA I-II.

Exclusion criteria

Exclusion criteria: Patients with a clotting disorder.

Design outcomes

Primary

MeasureTime frame
Number and time of postoperative nausea;Number and time of vomiting after operation;exhaust time;remedial measure;—

Countries

China

Contacts

Public ContactLichun Han

Shaanxi Province Tumor Hospital

hanlichun696@163.com+86 13609266499

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026